Showing results (451-460 of 883) with videos related to
Sort By:
Pageof 89
Heart Rhythm|August 9, 2020
Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemakerAatish Garg, Jayanthi N Koneru, Dedra H Fagan, et al.The American Journal of Cardiology|April 19, 2017
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])Tharian S Cherian, Peter Shrader, Gregg C Fonarow, et al.Journal of Cardiovascular Electrophysiology|February 11, 2026
Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 StudyPaul Dorian, Marco Alings, Benoit Coutu, et al.Heart Rhythm|March 3, 2009
Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trialMichael R Gold, Stuart Adler, Laurent Fauchier, et al.Journal of the American College of Cardiology|July 13, 2010
Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%Jonathan P Piccini, Aijing Z Starr, John R Horton, et al.Circulation. Cardiovascular Genetics|April 19, 2011
The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fractionAlbert Y Sun, Jason I Koontz, Svati H Shah, et al.American Heart Journal|November 2, 2020
Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular careJedrek Wosik, Megan E B Clowse, Robert Overton, et al.Journal of Cardiovascular Electrophysiology|September 13, 2023
Association of leadless pacing with ventricular and valvular functionKelly Arps, Bicong Li, John Carson Allen, et al.The American Journal of Cardiology|April 2, 2017
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])Benjamin A Steinberg, DaJuanicia N Simon, Laine Thomas, et al.Journal of Cardiovascular Electrophysiology|August 24, 2017
Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysisMarat Fudim, Richard Boortz-Marx, Arun Ganesh, et al.Pageof 89